GBD

Block 216 Receives LEED Gold Certification

Retrieved on: 
星期三, 三月 27, 2024

PORTLAND, Ore., March 27, 2024 /PRNewswire/ -- On March 13th, Block 216 was awarded LEED® Gold by the US Green Building Council. For developer BPM and GBD Architects, creating a green and sustainable building was a priority from the beginning of the project.

Key Points: 
  • PORTLAND, Ore., March 27, 2024 /PRNewswire/ -- On March 13th, Block 216 was awarded LEED® Gold by the US Green Building Council.
  • Located conveniently near the streetcar and buslines, Block 216's accessibility in Portland reduces the development's carbon footprint.
  • Since opening last Fall, Block 216 has welcomed guests from around the globe at the Ritz-Carlton, Portland, which opened to much acclaim from local, national and international media, and new owners at the Ritz-Carlton Residences, Portland.
  • The ground-floor food gallery, Flock, will open before the summer, where local chefs will showcase the best of Portland cuisine.

Lowey Dannenberg, P.C. Announces an Additional Settlement for Those Who Have Transacted in Euroyen-Based Derivatives Between January 1, 2006 through June 30, 2011

Retrieved on: 
星期四, 三月 21, 2024

The Settlement will provide an additional $35,000,000 to pay claims from persons who transacted in Euroyen-Based Derivatives from January 1, 2006 through June 30, 2011, inclusive.

Key Points: 
  • The Settlement will provide an additional $35,000,000 to pay claims from persons who transacted in Euroyen-Based Derivatives from January 1, 2006 through June 30, 2011, inclusive.
  • Before any money is paid, the Court will hold a Fairness Hearing to decide whether to approve the Settlement.
  • Contact your brokerage firm to see if you purchased, sold, held, traded, or otherwise had any interest in Euroyen-Based Derivatives.
  • These payments will also be deducted from the Settlement Fund before any distributions are made to the Settlement Class.

Menarini Asia-Pacific Enters into an Exclusive Licensing Agreement with Astellas to Commercialize Smyraf® in Taiwan and select South-East Asian markets

Retrieved on: 
星期三, 九月 13, 2023

Smyraf® has been approved in Taiwan and has patent protection for composition of matter until 2032.

Key Points: 
  • Smyraf® has been approved in Taiwan and has patent protection for composition of matter until 2032.
  • Subject to the terms of the agreement, Astellas will receive total payments of up to €5.5 million including upfront and milestone payments.
  • In addition, Menarini will pay Astellas a high-single digit percentage royalties on net sales of Smyraf®.
  • Menarini will have an option to extend the rights to select South-East Asian markets.

Menarini Asia-Pacific Enters into an Exclusive Licensing Agreement with Astellas to Commercialize Smyraf® in Taiwan and select South-East Asian markets

Retrieved on: 
星期三, 九月 13, 2023

Smyraf® has been approved in Taiwan and has patent protection for composition of matter until 2032.

Key Points: 
  • Smyraf® has been approved in Taiwan and has patent protection for composition of matter until 2032.
  • Subject to the terms of the agreement, Astellas will receive total payments of up to €5.5 million including upfront and milestone payments.
  • In addition, Menarini will pay Astellas a high-single digit percentage royalties on net sales of Smyraf®.
  • Menarini will have an option to extend the rights to select South-East Asian markets.

Psychobiotics Industry Analysis 2018-2022 & 2023-2028: Insights Into Stress Management, Mood Health & Mood Upliftment, Depression, Anxiety, Sleep Problems, and Other Applications - ResearchAndMarkets.com

Retrieved on: 
星期四, 八月 31, 2023

Moreover, the global pandemic triggered by COVID-19 and the subsequent worldwide lockdowns in 2020-2021 have amplified mental health struggles across diverse populations.

Key Points: 
  • Moreover, the global pandemic triggered by COVID-19 and the subsequent worldwide lockdowns in 2020-2021 have amplified mental health struggles across diverse populations.
  • The rise of probiotics as an avenue to address mood disorders, particularly anxiety and depression, marks a significant stride in mental health management.
  • Probiotics, through their interaction with the microbial-gut-brain axis, offer a means to modulate mood and overall health.
  • Market forms include powder, liquid/fluid, tablets, and more, while applications span stress management, mood enhancement, depression, anxiety, sleep disorders, and beyond.

Marcelo Brutti Returns as Hyundai Capital America's New CEO

Retrieved on: 
星期一, 四月 3, 2023

IRVINE, Calif., April 3, 2023 /PRNewswire/ -- Hyundai Capital America (HCA) has appointed Marcelo Brutti to be the President & Chief Executive Officer effective April 3.

Key Points: 
  • IRVINE, Calif., April 3, 2023 /PRNewswire/ -- Hyundai Capital America (HCA) has appointed Marcelo Brutti to be the President & Chief Executive Officer effective April 3.
  • He will report to Ross Williams, Executive Vice President, Head of Global Business Division (GBD) and Head of Hyundai Capital Americas Region.
  • After more than seven years as HCA's President & CEO, Ross Williams has taken a new role with Hyundai Capital Services (HCS) as Executive Vice President, Head of GBD.
  • Headquartered in Irvine, CA, Hyundai Capital America (HCA) is a top-10 U.S. auto finance company supporting the financial services needs of Hyundai Motor America, Genesis Motor America, and Kia America.

Click Therapeutics Receives FDA Breakthrough Device Designation for Prescription Digital Therapeutic to Treat Episodic Migraine

Retrieved on: 
星期五, 十二月 16, 2022

Click Therapeutics, Inc. (Click), a leader in Digital Therapeutics as prescription medical treatments, today announced that it has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for CT-132.

Key Points: 
  • Click Therapeutics, Inc. (Click), a leader in Digital Therapeutics as prescription medical treatments, today announced that it has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for CT-132.
  • Clicks CT-132 prescription digital therapeutic is under development as an adjunctive preventive treatment for episodic migraine in patients aged 18 years and older.
  • The program is designed to expedite the development and review of medical devices meeting Breakthrough criteria in the United States.
  • We are thrilled to receive this Breakthrough designation as it will facilitate collaborative discussions with the FDA and help expedite the process of bringing a first-in-class migraine digital therapeutic to patients, said Austin Speier, Chief Strategy Officer of Click Therapeutics.

JLMAG Awards the First SGS PAS 2060 Carbon Neutrality Declaration Certificate in the Global Rare Earth Permanent Magnet Industry

Retrieved on: 
星期四, 六月 30, 2022

PAS 2060 is the internationally recognized carbon neutrality standard, which requires enterprises to strive to reduce carbon emissions and achieve low-carbon production on the basis of quantifying greenhouse gas emissions.

Key Points: 
  • PAS 2060 is the internationally recognized carbon neutrality standard, which requires enterprises to strive to reduce carbon emissions and achieve low-carbon production on the basis of quantifying greenhouse gas emissions.
  • With regard to carbon emissions that cannot be reduced, PAS 2060 encourages enterprises to adopt voluntarily compensation and offset to achieve carbon neutrality.
  • The PAS 2060 carbon neutrality declaration certificate proved that JL MAG's efforts in carbon neutrality have been highly recognized by the international authorities.
  • The Company facilitates the pursuit of carbon neutrality in China and around the world by providing rare earth permanent magnets to its top player customers.

Bayer Launches Calantic™ Digital Solutions to help Address Radiology Industry Challenges

Retrieved on: 
星期二, 六月 28, 2022

Bayer today unveiled Calantic Digital Solutions, a new cloud-hosted platform delivering access to digital applications, including AI-enabled programs, for medical imaging.

Key Points: 
  • Bayer today unveiled Calantic Digital Solutions, a new cloud-hosted platform delivering access to digital applications, including AI-enabled programs, for medical imaging.
  • It is crucial to drive innovation in this area and broaden access to digital tools that can help address the rising demand for solutions which improve the speed and accuracy of diagnoses.
  • Built on our leading industry knowledge and deep medical understanding across a multitude of diagnostic and therapeutic areas, Calantic Digital Solutions underlines our commitment to continue accelerating innovation for the benefit of patients and their physicians, says Gerd Krger, Head of Radiology, Bayer Pharmaceuticals.
  • Calantic Digital Solutions is a suite of digital radiology AI-enabled applications which assist radiologists and their teams at critical steps within a patients treatment journey.

Founder of Great by Design, Aariah Woods, Launches Another Dropshipping Course to Empower Marketers

Retrieved on: 
星期一, 六月 13, 2022

The market valuation of the dropshipping industry is expected to touch $557.9 billion by 2025.

Key Points: 
  • The market valuation of the dropshipping industry is expected to touch $557.9 billion by 2025.
  • The leading coach and entrepreneur Aariah has launched the Shopify beginner course and webinar to provide the best and most crucial information about dropshipping on Shopify.
  • Aariah Wood's brainchild, Great By Design college, aims to provide expert guidance, growth solutions, and support to struggling marketers and entrepreneurs.
  • With over 60 thousand students who have become successful marketers, GBD college continuously grows and creates new entrepreneurs every day.